Physiomics Plc (LON:PYC – Get Free Report) rose 4.1% during mid-day trading on Thursday . The stock traded as high as GBX 0.78 ($0.01) and last traded at GBX 0.78 ($0.01). Approximately 1,979,196 shares were traded during mid-day trading, an increase of 16% from the average daily volume of 1,709,716 shares. The stock had previously closed at GBX 0.75 ($0.01).
Physiomics Price Performance
The company has a market capitalization of £1.59 million, a P/E ratio of -13.83 and a beta of 1.69. The company has a 50 day moving average of GBX 0.69 and a 200-day moving average of GBX 0.76.
Insider Transactions at Physiomics
In related news, insider Peter Sargent purchased 459,090 shares of the firm’s stock in a transaction that occurred on Thursday, November 7th. The stock was bought at an average cost of GBX 1 ($0.01) per share, with a total value of £4,590.90 ($5,753.01). Corporate insiders own 4.18% of the company’s stock.
About Physiomics
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.
Recommended Stories
- Five stocks we like better than Physiomics
- Most active stocks: Dollar volume vs share volume
- Top 3 Investment Themes to Watch for in 2025
- Where Do I Find 52-Week Highs and Lows?
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- How Can Investors Benefit From After-Hours Trading
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.